BGF has exitedf its investment in Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). Following a period of growth and expansion, the business has been acquired by Quotient Sciences, the drug development and manufacturing accelerator, backed by the global private equity firm Permira.